GISTs, the most common soft tissue sarcomas of the GI tract, most commonly contain KIT- or PDGFRA-activating mutations and are derived from mesenchymal neoplasms in the GI tract [11–13]. The gene discussed is PDGFRA; the disease is mesenchymal cell neoplasm.